Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1590 of 6351
-
Visual biofeedback may help children master the /s/ sound
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the efficacy of sibilant biofeedback treatment delivered via telepractice in six children ages 8:0-17;11 who present with distortions of /s/. The main questions it aims to answer are: * Primary hypothesis: Biofeedback treatment for …
Sponsor: Montclair State University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for tough leukemia? early trial of AOH1996 begins
Disease control Recruiting nowThis phase 1 trial tests safety, side effects, and best dose of AOH1996 for the treatment of patients with acute myeloid leukemia (AML) that has come back after a period of improvement (relapsed) or AML that has not responded to previous treatment (refractory). AOH1996 is in a cl…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New pill could help ITP patients who failed other treatments
Disease control Recruiting nowThe purpose of the phase 1 part of this study was to evaluate how well pirtobrutinib is tolerated and what side effects may occur. The phase 2 part of the study will further investigate efficacy and safety of multiple pirtobrutinib dosages versus placebo. The study drug will be …
Phase 1/2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New mapping tech aims to improve heart ablation for AFib patients
Disease control OngoingThe study is designed to collect data on the acute and long-term (1 year) safety and effectiveness outcome when an ablation procedure is performed in a commercial and standard of care setting with the FARAPULSE™ Pulsed Field Ablation System, whereby the FARAWAVE NAV Ablation cath…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Could a probiotic during pregnancy help babies grow stronger?
Disease control Recruiting nowBurden: Environmental Enteric Dysfunction (EED) is an enteropathic condition characterized by altered gut permeability, infiltration of immune cells and changes in villous architecture and cell differentiation. EED is a major reason of malnourishment, poor neurological developmen…
Phase 2 • Sponsor: University Ghent • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug candidate BL-M05D1 enters early human trials for tough cancers
Disease control OngoingThe objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects with Advanced or Metastatic Solid Tumors.
Phase 1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Could a tiny implant cure your sleep apnea?
Disease control Recruiting nowThis is a study to determine if the Lunair Alpha System is safe and effective for treating moderate to severe sleep disordered breathing.
Sponsor: Lunair Medical • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can a mindfulness program curb youth suicide? new study aims to find out
Symptom relief Recruiting nowThe goal of this clinical trial is to develop and evaluate youth-focused intervention programs for suicide and self-harm that are tailored to the psychological, developmental, and cultural characteristics of Korean adolescents and young adults. The study examines whether two stru…
Sponsor: Ajou University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
New hope for babies with rare dwarfism: daily shot may boost growth
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and efficacy of daily administration of vosoritide in participants with HCH aged 0 to \< 36 months over a 52-week period.
Phase 2 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Experimental drug triapine paired with radiation targets recurrent brain cancers
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of triapine in combination with radiation therapy in treating patients with glioblastoma or astrocytoma that has come back after a period of improvement (recurrent). Triapine may stop the growth of tumor cells by bl…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
A digital guide may cut long sick leave for workers with muscle and joint pain
Disease control Recruiting nowThe objective of the Back on Track study is to evaluate a computer-assisted reintegration protocol for musculoskeletal disorders of a major occupational health service in the Netherlands on its (cost-)effectiveness and conduct a process evaluation. The computer-assisted reintegra…
Sponsor: Amsterdam UMC, location VUmc • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
One test, four diseases: could this be the end of missed diagnoses?
Diagnosis Recruiting nowPerformance study to evaluate the clinical performance of the In-Vitro Diagnostics Medical Device MagIA H3S (a Multiplex Point-of-Care test for the combined detection of Human Immunodeficiency Virus (HIV), Hepatitis B and C and Syphilis) from serum, plasma samples collected prosp…
Sponsor: MagIA Diagnostics • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
New hope for arthritis sufferers? CIT-013 drug trial begins
Disease control Recruiting nowThe goal of this clinical trial is to learn if CIT-013 works to treat rheumatoid arthritis in adults. It will also learn about the safety of CIT-013. The main questions it aims to answer are: Does CIT-013 lower the disease activity of RA patients? What medical problems do partic…
Phase 2 • Sponsor: Citryll BV • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Promising enzyme therapy for kids with rare fabry disease enters key trial
Disease control Recruiting nowA Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents with Fabry Disease.
Phase 2/3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could fewer files mean less pain after root canals?
Disease control CompletedThis randomized controlled clinical trial aims to evaluate the effect of the number of rotary files on working length negotiation and postoperative pain in the second mesiobuccal (MB2) canals of maxillary first molars. Patients are assigned to one of four groups according to the …
Sponsor: Mehmet Adıgüzel • Aim: Disease control
Last updated Sep 10, 2026 02:00 UTC
-
New drug combo targets Hard-to-Treat head and neck cancer
Disease control Recruiting nowThis study is a single center, non-randomized, prospective phase II clinical trial to evaluate the efficacy and safety of Iparomlimab and Tuvonralimab in patients with with recurrent/metastatic head and neck squamous cell carcinoma failed second-line treatment. The participants w…
Phase 2 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug targets rare cancer mutation in early trial
Disease control OngoingThis is a Phase 1, open-label study to evaluate the safety and tolerability of ATV-1601 administered orally in adults with AKT1 E17K-mutant, advanced solid tumors and also in HR+/HER2- advanced and metastatic breast cancer, with or without fulvestrant.
Phase 1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New gentle chemo combo after transplant aims to stop leukemia relapse
Disease control Recruiting nowThe goal of this interventional clinical trial is to determine if low doses of gentle chemotherapy after bone marrow transplant may prevent relapse and promote an increase in survival and decrease in side effects in participants with acute myeloid leukemia and myelodysplastic syn…
Phase 1/2 • Sponsor: Benjamin Tomlinson • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Poop pills aim to stamp out superbugs in the gut
Disease control Recruiting nowThe goal of this clinical trial is to learn if oral capsules containing lyophilized stool from healthy donors (fecal microbiota transplantation or FMT) can safely and effectively decolonize multidrug-resistant organisms (MDROs) from the intestines in adults. The main questions it…
Phase 1/2 • Sponsor: University of Rijeka • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for myelofibrosis: drug combo targets tough cases
Disease control OngoingThis is a Phase Ib/II clinical study to evaluate the safety , efficacy and pharmacokinetics of WJ01024 tablets combined with Ruxolitinib tablets in patients with myelofibrosis.The study will be conducted in two phases: Phase 1b and Phase 2.Phase Ib is a dose extension study of WJ…
Phase 1/2 • Sponsor: Suzhou Junjing BioSciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC